Provided by Tiger Fintech (Singapore) Pte. Ltd.

CEL-SCI Corp

7.09
+0.45006.78%
Post-market: 7.300.2100+2.96%17:49 EDT
Volume:139.50K
Turnover:1.01M
Market Cap:56.67M
PE:-0.78
High:7.56
Open:6.88
Low:6.88
Close:6.64
52wk High:32.70
52wk Low:1.98
Shares:7.99M
Float Shares:6.64M
Volume Ratio:0.78
T/O Rate:2.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.0813
EPS(LYR):-15.3110
ROE:-328.04%
ROA:-70.09%
PB:8.07
PE(LYR):-0.46

Loading ...

Press Release: GERDAU S.A. - CONSOLIDATED INFORMATION

Dow Jones
·
Yesterday

CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference

Reuters
·
Oct 20

Half-Yearly Results

GlobeNewswire
·
Oct 14

CELSCI Corporation to Present at LD Micro Main Event Investor Conference

Reuters
·
Oct 10

Positive Buy Rating for Palvella Therapeutics Driven by Promising CVM Treatment and Market Potential

TIPRANKS
·
Oct 09

Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CM

GlobeNewswire
·
Sep 28

Sheyang County Accelerates High-Quality Development Through Multi-Dimensional Growth Strategy

Deep News
·
Sep 18

First Berlin Equity Research Reiterates BUY Rating for CEL-SCI Corporation, Sets Price Target at USD 60

Reuters
·
Sep 01

Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label Extension

GlobeNewswire
·
Aug 30

CEL-SCI Corporation Completes $10 Million Public Offering to Advance Cancer Immunotherapy Development

Reuters
·
Aug 30

CEL-SCI Corp Shares Plunge Over 30% Following $10 Million Public Offering Pricing Announcement

Deep News
·
Aug 28

BUZZ-U.S. STOCKS ON THE MOVE-Dollar General, Best Buy, Teva Pharmaceutical

Reuters
·
Aug 28

CEL-SCI Shares Drop 30% Premarket After Co Announces Pricing of $10 Mln Stock Offering

THOMSON REUTERS
·
Aug 28

Cel-Sci Prices $10 Million Stock Offering

MT Newswires Live
·
Aug 28

CEL-SCI Announces Pricing of $10 Million Public Offering

THOMSON REUTERS
·
Aug 28

BUZZ-Drug developer CEL-SCI plunges after unveiling stock offering

Reuters
·
Aug 28

BRIEF-CEL-SCI Announces Proposed Public Offering

Reuters
·
Aug 28

CEL-SCI Corporation Announces Public Offering to Sell Common Stock and Pre-Funded Warrants

Reuters
·
Aug 28

BridgeBio to Present Additional Open-label Extension Data from ATTRibute-CM at ESC Congress 2025

GlobeNewswire
·
Aug 25

CEL-SCI Corporation Awaits Saudi Food and Drug Authority's Decision on Breakthrough Medicine Designation for Multikine in Saudi Arabia

Reuters
·
Aug 25